Company profile: Continuum Clinical
1.1 - Company Overview
Company description
- Provider of Health Economics and Outcomes Research services and clinical trial engagement solutions, including the MERIS Total Engagement suite for participant and site support with real-time performance data; patient recruitment campaigns; Global Site Solutions; study/site support; retention solutions; and patient advocacy and diversity & inclusion services.
Products and services
- MERIS Total Engagement Solution: A globally compliant technology suite architects clinical trial participation for participants and research sites, producing real-time, actionable performance data for sponsors to oversee and optimize trials
- Study and Site Support: Global services engage, prepare, and support sites to meet or exceed enrollment targets, including developing study materials, assembling site kits, and delivering patient education resources
- Global Site Solutions (GSS): An enrollment-focused team handles recruitment efforts and site-level tasks so study sites can dedicate more time to the trial itself
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Continuum Clinical
M2i Life Sciences
HQ: France
Website
- Description: Provider of custom synthesis and formulation of niche healthcare products (mainly generics), with activities in veterinary art, biological crop protection, and organic electronics. Offers redesign of synthetic routes for hard-to-make molecules, analytical services (method development, physico-chemical characterization, diffusion/stability studies), access to high-tech analytical equipment, and the Lobesia Pro Spray.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full M2i Life Sciences company profile →
Synteract HCR
HQ: United States
Website
- Description: Provider of global full-service contract research organization support for biotechnology, medical device, and pharmaceutical companies across all phases of clinical development, delivering customized Phase I–IV services collaboratively and cost effectively.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synteract HCR company profile →
Emergent Health
HQ: United States
Website
- Description: Provider of regenerative medicine, including nutraceuticals and phytonutritionals, developing and selling products such as Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emergent Health company profile →
Celerion
HQ: United States
Website
- Description: Provider of early clinical research and Applied Translational Medicine, translating research discoveries into knowledge of drug action in humans to support early development decisions. Services include bioanalytical sciences for small and large molecules; clinical development (safety, PK/PD); data management and biometrics; global drug development (regulatory, project management); EDC; and eTMF via secure, DIA-formatted portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celerion company profile →
Bioqual
HQ: United States
Website
- Description: Provider of AAALAC-accredited pre-clinical research and model development services, offering in vivo studies in small and large animal models, in vitro services (sample processing, virus stock generation, and assays including virus neutralization, hemagglutination inhibition, and quantitative PCR), vaccine evaluation (therapeutics and microbicides), drug therapy testing, and consulting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioqual company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Continuum Clinical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Continuum Clinical
2.2 - Growth funds investing in similar companies to Continuum Clinical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Continuum Clinical
4.2 - Public trading comparable groups for Continuum Clinical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →